@inproceedings{inproceedings, title  = {{Fifty-two-week laboratory safety findings from an open-label extension study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Cork MJ and Lockshin B and Blauvelt A and Chen Z and Vakil J and Khokhar FA}},

 volume = {{185}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{E121-E121}},

 note = {{Accessed on 2024/12/22}}}